InnoCell Clinic
Your Partner in iPSC-Derived 3D Preclinical Test Systems
Advancing preclinical research with high-standard solutions for toxicology, mechanism-of-action studies, and disease modeling using diverse stem cell-derived tissue platforms.
Our mission is to accelerate pharmaceutical and cosmetic innovation by providing human stem cell-based 3D models that replace animal testing and deliver more predictive results.
-
Changing global regulatory landscape
Global regulators (FDA, EMA and China’s NMPA) are phasing out animal testing and now endorse advanced alternatives such as stem cell–based models and organoids, accelerating adoption of human-relevant models.
-
Internationally recognized team of experts
The development of the technologies we employ is carried out by internationally recognized experts and professionals in the fields of stem cell research and drug development.